Key Finding
Acupuncture combined with conventional treatment significantly improved brain tissue metabolism markers (NAA/Cr and Cho/Cr ratios) and neurological function scores (NIHSS, FMA, and MoCA) in ischemic stroke patients compared to conventional treatment alone.
Researchers analyzed nine clinical trials involving 602 patients to understand how acupuncture affects brain metabolism and function after ischemic stroke. Ischemic stroke occurs when blood flow to the brain is blocked, causing damage to brain tissue. The study used advanced brain imaging to measure specific chemical markers that indicate brain health and recovery.
The researchers found that when acupuncture was added to standard stroke treatment, patients experienced significant improvements compared to those receiving only standard care. Brain scans showed healthier tissue metabolism, with increases in NAA/Cr ratios (a marker of healthy neurons) and decreases in Cho/Cr ratios (a marker of tissue damage). Patients who received acupuncture also scored better on tests measuring stroke severity, motor function (ability to move affected limbs), and cognitive function (thinking and memory skills).
Specifically, acupuncture patients showed measurable improvements in their National Institutes of Health Stroke Scale scores (indicating reduced stroke severity), Fugl-Meyer Assessment scores (showing better movement recovery), and Montreal Cognitive Assessment scores (reflecting improved mental function). These improvements in both brain chemistry and practical functioning suggest that acupuncture may help the brain heal more effectively after stroke.
The researchers noted that while these results are promising, more high-quality studies with larger patient groups are needed to confirm these benefits. The evidence shows that acupuncture, when combined with conventional stroke rehabilitation, appears to enhance recovery without replacing standard medical care. If you're considering acupuncture after a stroke, consult with your medical team and seek treatment from a licensed acupuncturist experienced in stroke rehabilitation.
This systematic review and meta-analysis examined nine RCTs (n=602) investigating acupuncture's effects on cerebral metabolism and neurological outcomes in ischemic stroke patients. Magnetic resonance spectroscopy measured metabolite ratios in lesion centers. Results demonstrated significant improvements with acupuncture versus controls: NAA/Cr ratio increased (MD=0.19, 95% CI 0.14-0.24, p<0.00001), Cho/Cr ratio decreased (MD=-0.25, 95% CI -0.36 to -0.15, p<0.00001), indicating improved neuronal integrity and reduced membrane turnover. No significant change occurred in Lac/Cr ratios. Clinical outcomes showed significant improvements: NIHSS scores decreased (MD=-2.84, 95% CI -3.76 to -1.92, p<0.00001), FMA scores increased (MD=12.94, 95% CI 7.07-18.81, p<0.0001), and MoCA scores improved (MD=3.20, 95% CI 2.30-4.10, p<0.00001). These findings suggest acupuncture as adjunctive therapy enhances both cerebral metabolism at the lesion site and functional neurological recovery. Quality assessment used Cochrane risk of bias tools. Authors acknowledge limited evidence for specific measures and recommend larger, high-quality RCTs for stronger clinical recommendations.
Browse our directory of verified licensed practitioners near you.
Find a practitioner โ๐ Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
๐ Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
๐ Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.